Now Accepting Applications: POCTRN Solicitation 2021 - POCTRN
null Now Accepting Applications: POCTRN Solicitation 2021
POCTRN Solicitation 2021
Do you have a promising point-of-care medical technology in need of further development?
Do you have a promising point-of-care medical technology in need of further development? The NIH’s Point-of-Care Technology Research Network (POCTRN) drives the development of point-of-care technologies through collaborative efforts that merge scientific and technological capabilities with clinical need.
We are pleased to announce new funding opportunities from our centers:
- Microfluidics/Lab-on-a-Chip Point-of-Care Technologies - Expressions of Interest are due March 15, 2021.
Atlanta Center for Microsystems Engineered Point-of-Care Technologies
- Development of Point-Of-Care Testing for HIV and Co-Morbidities for Use in Low and Middle Income Countries -Expressions of Interest are due March 15, 2021
The Center for Innovation in Point of Care Technologies for HIV/AIDS at Northwestern
- Center for Advancing Point of Care Technologies in Heart, Lung, Blood and Sleep Disorders: Funding Opportunity - Expressions of Interest are due March 1, 2021.
Center for Advancing Point of Care Technologies in Heart, Lung, Blood, and Sleep Disorders
- Johns Hopkins University Center for Point of Care Technologies Research for Sexually Transmitted Diseases
This center will not be issuing a solicitation in 2021 but is instead approaching companies who submitted applications for COVID diagnostics through the RADx initiative to gauge their interest in pivoting their platforms to the detection of STDs.
RADx: Rapid Acceleration of Diagnostics
In response to the COVID-19 pandemic, the Rapid Acceleration of Diagnostics (RADxsm) initiative was formed to accelerate the development, validation, and commercialization of innovative point-of-care and home-based tests, as well as improvements to clinical laboratory tests, that can directly detect SARS-CoV-2, the virus that causes COVID-19.
In the News
Two New Over-the-Counter At-Home COVID-19 Tests Brought to U.S. Market Quickly by Biden-Harris Administration
New HHS actions add to Biden administration efforts to increase access to easy-to-use over-the-counter COVID-19 tests
NIH RADx initiative expands COVID-19 testing innovation for additional types of rapid tests
The need for new test verification and regulatory support for innovative diagnostics
NIH-funded screening study builds case for frequent COVID-19 antigen testing
RADx partnerships speed new COVID testing
Publication reveals essential ingredients of the groundbreaking NIH RADx national diagnostics effort
Innovative COVID-19 Testing RADx Tech Reports Unveiled in Special Issue of IEEE Open Journal of Engineering in Medicine and Biology
Luminostics Announces FDA Authorization and Production Scale-Up of US-Manufactured Smartphone-Based COVID-19 Rapid Test
RADx Expects COVID-19 Portfolio to Accelerate an Era of At-Home Infectious Disease Testing (Login Required)
VIC Foundry, Inc. Receives NIH RADx Funding for Development of an At-home Molecular Diagnostic Test for COVID-19
Ceres Nanosciences Opens Advanced Particle Manufacturing Plant in Northern Virginia to Expand Nanotrap® Particle Manufacturing Capacity for COVID-19 Testing
COVID-19 Testing: Three Breakthrough Solutions in the RADx Initiative
NIH Director: Collaboration Amid Chaos, and Biden’s First 100 Days - How Francis Collins sees the COVID response changing with the new administration
The National Strategy From the COVID-19 Response and Pandemic Preparedness
Winners of HHS Design-a-thon to Develop Innovative Digital Health Tools for COVID-19 At-Anywhere Diagnostic Tests Announced